Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Stroke genetics informs drug discovery and risk prediction across ancestries.

Journal article

Mishra A. et al, (2022), Nature, 611, 115 - 123

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Journal article

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845

Multiplexed apolipoprotein profiling advances the assessment of residual lipid-related cardiovascular risk

Conference paper

Schmidt L. et al, (2022), CARDIOVASCULAR RESEARCH, 118

Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations.

Journal article

Temprano-Sagrera G. et al, (2022), J Thromb Haemost, 20, 1331 - 1349

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

CHALLENGES IN EXTRAPOLATION WHEN THERE ARE MULTIPLE HEALTH OUTCOMES

Conference paper

Willliam C. et al, (2022), VALUE IN HEALTH, 25, S358 - S358

The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics.

Journal article

Spartera M. et al, (2021), Eur Heart J Cardiovasc Imaging

Genome-Wide Association Study of Peripheral Artery Disease.

Journal article

van Zuydam NR. et al, (2021), Circ Genom Precis Med

Impact of ACLY on type 2 diabetes in UK Biobank: a Mendelian randomisation study

Conference paper

Stiby A. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3011 - 3011

Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention

Presentation

Lui NMJ. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3159 - 3159

Load More